Skip to content
★ Sign in to follow
ME

Maria Engström

Cinclus Pharma Holding AB (publ)
Total declarations
4
Company
1
▲ Purchases (4 ops.)
€10k
▼ Sales (0 ops.)
—

Latest filing published 20 Jun 2024 for Cinclus Pharma Holding AB (publ), €2,765.

Filing timeline

BuySale
Maria Engström

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4
Positive at T+90
0%
Median T+90
-15.7%

Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Maria Engström: trading record in brief

All filings by Maria Engström on record concern Cinclus Pharma Holding AB (publ). In total, 4 filings cover trades dated 20 June 2024.

Every open-market trade on record is a purchase: 4 purchases worth €10k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

A typical purchase (the median) is worth €2,894. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 4 purchases show a median change of -15.7%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.

Most recently, on 20 June 2024, the filings show an open-market purchase worth €2,765 in Cinclus Pharma Holding AB (publ). The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Maria Engström

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesCinclus Pharma Holding AB (publ)
    31,080 SEK40FI-SE
    740 shares@ SEK 42.0027.0% of flowAktieISIN SE0020388577FI:csv-d11fa1358863acfc828a
    Canonical exit: 18 Sept 2024 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesCinclus Pharma Holding AB (publ)
    15,540 SEK38FI-SE
    370 shares@ SEK 42.0013.5% of flowAktieISIN SE0020388577FI:csv-d6c17d7fcd9ced53dbe0
    Canonical exit: 18 Sept 2024 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesCinclus Pharma Holding AB (publ)
    34,500 SEK40FI-SE
    1,000 shares@ SEK 34.5030.0% of flowAktieISIN SE0020388577FI:csv-f44ae8ef072aa8295272
    Canonical exit: 18 Sept 2024 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesCinclus Pharma Holding AB (publ)
    34,000 SEK40FI-SE
    1,000 shares@ SEK 34.0029.5% of flowAktieISIN SE0020388577FI:csv-beeb89c7a52b742d218d
    Canonical exit: 18 Sept 2024 (T+90)

4 of 4 declarations